Tenax Therapeutics, Inc. (TENX)

Tenax Therapeutics Statistics

Total Valuation

TENX has a market cap or net worth of $298.73 million. The enterprise value is $193.26 million.

Market Cap	298.73M
Enterprise Value	193.26M

Important Dates

The next estimated earnings date is Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TENX has 39.99 million shares outstanding. The number of shares has increased by 3,453.40% in one year.

Current Share Class	4.56M
Shares Outstanding	39.99M
Shares Change (YoY)	+3,453.40%
Shares Change (QoQ)	+8.17%
Owned by Insiders (%)	0.14%
Owned by Institutions (%)	11.29%
Float	4.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.86
P/TBV Ratio	2.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 41.89

Current Ratio	41.89
Quick Ratio	41.73
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5,840.67

Financial Efficiency

Return on equity (ROE) is -56.12% and return on invested capital (ROIC) is -38.94%.

Return on Equity (ROE)	-56.12%
Return on Assets (ROA)	-37.61%
Return on Invested Capital (ROIC)	-38.94%
Return on Capital Employed (ROCE)	-33.91%
Revenue Per Employee	n/a
Profits Per Employee	-$5.25M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +62.75% in the last 52 weeks. The beta is 1.58, so TENX's price volatility has been higher than the market average.

Beta (5Y)	1.58
52-Week Price Change	+62.75%
50-Day Moving Average	6.76
200-Day Moving Average	6.23
Relative Strength Index (RSI)	57.97
Average Volume (20 Days)	97,621

Short Selling Information

The latest short interest is 754,325, so 1.89% of the outstanding shares have been sold short.

Short Interest	754,325
Short Previous Month	553,719
Short % of Shares Out	1.89%
Short % of Float	16.74%
Short Ratio (days to cover)	5.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-35.04M
Pretax Income	-31.48M
Net Income	-31.48M
EBITDA	n/a
EBIT	-35.04M
Earnings Per Share (EPS)	-$0.94

Balance Sheet

The company has $105.46 million in cash and n/a in debt, giving a net cash position of $105.46 million or $2.64 per share.

Cash & Cash Equivalents	105.46M
Total Debt	n/a
Net Cash	105.46M
Net Cash Per Share	$2.64
Equity (Book Value)	103.33M
Book Value Per Share	2.61
Working Capital	103.33M

Cash Flow

Operating Cash Flow	-19.84M
Capital Expenditures	n/a
Free Cash Flow	-19.84M
FCF Per Share	-$0.50

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TENX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3,453.40%
Shareholder Yield	-3,453.40%
Earnings Yield	-10.54%
FCF Yield	-6.64%

Analyst Forecast

The average price target for TENX is $16.67, which is 123.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.67
Price Target Difference	123.16%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 3, 2024. It was a reverse split with a ratio of 1:80.

Last Split Date	Jan 3, 2024
Split Type	Reverse
Split Ratio	1:80

Scores

Altman Z-Score	n/a
Piotroski F-Score	2